Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | +1.89% | -7.69% | -0.92% |
May. 09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.92% | 204M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+28.31% | 12.16B | |
+24.73% | 12.17B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- BioTime, Inc. Appoints Chase C. Leavitt as General Counsel and Corporate Secretary